🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users administering products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated keywords and query recommendations. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also discovered communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

After moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly significant health risks”.